Breaking

Archive

May 2 results
16:15
16:15

UVRI to Study Moderna, Sanofi Efficacy in Protecting People at Risk of Critical COVID-19 Ministry of Health 2

She said participants will be divided into three groups. The first one will get one jab, the other two jabs, and the last one three jabs to see if they get protected against developing the symptomatic disease, critical illness requiring hospitalization, and if they are protected against emerging variants such as the latest omicron variant.
14:58
14:58

Moderna COVID-19 Vaccine Appears to Work against New Lethal Strains

According to the latest statement by the drug maker, laboratory tests on individuals vaccinated with the vaccine found the drug to produce neutralizing titers against all key emerging variants tested including one identified in the UK and another in South Africa.
May 2 results